Editorial: New insights into innate immune cell-based immunotherapies in cancer
Anne Caignard,
Mary Poupot-Marsan,
Virginie Lafont,
Daniela Wesch,
Chiara Porta,
Chiara Porta
Affiliations
Anne Caignard
Institut National de la Santé et de la Recherche Médicale (INSERM) U1160, Institut de Recherche Saint-Louis Hôpital Saint Louis, Paris, France
Mary Poupot-Marsan
Centre de Recherche en Cancérologie de Toulouse (CRCT), UMR1037 Institut National de la Santé et de la Recherche Médicale (Inserm)-Univ. Toulouse III Paul Sabatier-ERL5294 Centre National de la Recherche Scientifique (CNRS), 2 avenue Hubert Curien Oncopole de Toulouse, CS53717, Toulouse, France
Virginie Lafont
Institut de Recherche en Cancérologie de Montpellier (IRCM), Institut National de la Santé et de la Recherche Médicale (INSERM) U1194, Univ Montpellier, Institut du Cancer de Montpellier (ICM), Montpellier, France
Daniela Wesch
Institute of Immunology, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany
Chiara Porta
Department of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy
Chiara Porta
Center for Translational Research on Autoimmune & Allergic Diseases (CAAD), University of Eastern Piedmont, Novara, Italy
